Trials
Search / Trial NCT05653076

Hibiscus Sabdariffa Extract Effect on Neuromuscular Performance

Launched by UNIVERSIDAD DE GRANADA · Dec 7, 2022

Trial Information

Current as of February 05, 2025

Unknown status

Keywords

Nutritional Ergogenics Sport Supplementation Anthocyanins Polyphenols Antioxidants Strength

ClinConnect Summary

This clinical trial is studying the effects of Hibiscus sabdariffa extract on neuromuscular performance, particularly after intense strength training. Exercise-induced muscle damage (EIMD) can make it hard for athletes to perform at their best after a tough workout. The researchers believe that taking Hibiscus sabdariffa, which is rich in antioxidants, might help reduce these muscle problems and improve performance. The trial will look at how well participants can jump, lift weights, and change direction after exercise, measuring these abilities 24 and 72 hours post-workout.

To join the study, participants need to be between 18 and 35 years old, have a healthy body weight, and have been training in strength sports for at least a year. They should also be able to understand the study instructions. However, people with certain health conditions, those who take specific medications, or those who regularly use antioxidant-rich supplements are not eligible. If you participate, you'll receive either the Hibiscus extract or a placebo (a non-active pill) and will help researchers learn more about how this extract may benefit athletic performance.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Age: 18-35 years.
  • Body mass index: 18.5-30 kg/m2
  • Be able to understand the instructions, objectives, and protocol of the study.
  • Trained in some force sports discipline ≥1 year prior to the study and accustomed to carrying out the exercises of the evaluation protocol.
  • Exclusion Criteria:
  • History of a major adverse cardiovascular event, renal failure, cirrhosis, eating disorder, polycystic ovarian syndrome, weight control surgery, type 2 diabetes mellitus, or HIV/AIDS.
  • Any chronic pathology in which the intake of nutritional supplements is not recommended.
  • Any condition that, in the investigator's judgment, impairs the ability to participate in the study or represents a personal risk to the participant.
  • Use of medications that may affect the results of the study.
  • Unstable body weight for 3 months prior to study start (\>4 kg weight gain or loss)
  • Routine use of teas/infusions/supplements rich in polyphenols.
  • Pregnancy and lactation.
  • Active tobacco or illicit drug use or history of treatment for alcohol abuse.
  • To be on a special diet or prescribed for other reasons (eg celiac disease).

About Universidad De Granada

The Universidad de Granada is a prestigious academic institution in Spain, renowned for its commitment to research and innovation in the medical and health sciences. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide range of clinical trials designed to advance medical knowledge and improve patient care. Its dedicated team of researchers and clinicians work closely to ensure the ethical conduct and scientific rigor of all trials, contributing to the advancement of evidence-based medicine. The Universidad de Granada is dedicated to fostering an environment that promotes excellence in research, ultimately aiming to translate findings into clinical practice for the benefit of society.

Locations

Granada, , Spain

Granada, , Spain

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials